Latest Research
All publications from the Cancer3.AI database, newest first.
Primary thoracic synovial sarcoma in a 45-year-old male: A case report and literature review.
Liang B, et al
Researchers report a rare case of primary thoracic synovial sarcoma (PTSS) in a 45-year-old male patient who presented with chronic cough and occasional shortness of breath, with imaging revealing a large tumor mass in the left thoracic cavity. Initial preoperative biopsy incorrectly identified the tumor as a solitary fibrous tumor, but postoperative molecular analysis confirmed synovial sarcoma through detection of the hallmark t(X;18)(p11.2;q11.2) chromosomal translocation, highlighting how standard biopsy alone can be misleading for this tumor type. The patient underwent surgical resection followed by adjuvant chemotherapy with doxorubicin and nedaplatin, yet developed widespread metastatic disease only 8 months after surgery and died 18 months later due to tumor dissemination and associated complications. This case underscores that primary thoracic synovial sarcoma carries a poor prognosis and that molecular genetic testing is essential for accurate diagnosis when imaging and routine pathology yield ambiguous results. Clinicians should maintain heightened awareness of rare thoracic tumors such as PTSS to avoid diagnostic delays that may compromise timely and appropriate treatment.
Oncology letters
Source →Anti-Ma2 Paraneoplastic Encephalitis and Testicular Cancer: When the Hypothalamus Whispers-A Case Report and Systematic Review with Emphasis on Hypothalamic-Endocrine Dysfunction.
Zamponi V, et al
Researchers present a case report and systematic review examining paraneoplastic limbic encephalitis (PLE) driven by anti-Ma2 antibodies in patients with testicular cancer, with a specific focus on hypothalamic and endocrine complications that are rarely recognized or reported. A 21-year-old male who initially recovered following orchifuniculectomy and immunosuppressive therapy subsequently developed new-onset temporal seizures, decreased libido, and a polyuria-polydipsia syndrome four years after his original treatment, ultimately diagnosed as partial central diabetes insipidus using a water deprivation test and copeptin measurement. A PRISMA-guided systematic review of 11 studies encompassing 38 patients with anti-Ma2-associated PLE and testicular cancer found that 42% exhibited hypothalamic or diencephalic involvement, yet explicit endocrine manifestations were documented in only four cases and central diabetes insipidus in just two. These findings strongly suggest that hypothalamic-endocrine dysfunction is substantially underdiagnosed in this population, and that it can emerge years after successful tumor treatment. Clinicians managing young men with testicular cancer and anti-Ma2 PLE should implement long-term endocrine surveillance and use dynamic diagnostic testing to differentiate central diabetes insipidus from primary polydipsia when polyuria and polydipsia are present.
Medical sciences (Basel, Switzerland)
Source →Case Report: Two cases of primary malignant melanoma of the female genital tract and literature review.
Li Q, et al
Researchers report two cases of primary malignant melanoma of the cervix (PMMC), an exceedingly rare and aggressive gynecologic cancer for which no standardized treatment guidelines currently exist. Both patients presented with vaginal bleeding; one was postmenopausal with no visible cervical pigmentation, while the other was premenopausal with a visually distinct brown, friable cervical mass, and diagnosis was confirmed by histopathology in both. The first patient underwent radical surgery alone and died of disease recurrence 36 months later, while the second received a multimodal regimen combining surgery, chemotherapy, the anti-angiogenic agent bevacizumab, and the PD-1 immune checkpoint inhibitor Tislelizumab, achieving significant regression of pulmonary metastases after only two treatment cycles. A literature review of nine additional PMMC cases treated with PD-1/PD-L1 inhibitors found that 80% of patients still experienced disease progression despite immunotherapy, and PD-L1 expression was not a reliable predictor of treatment response. These findings highlight the severe clinical challenges posed by PMMC and suggest that multimodal strategies integrating surgery, chemotherapy, anti-angiogenic therapy, and immunotherapy may offer meaningful benefit where single-modality approaches fall short.
Frontiers in immunology
Source →Mucoepidermoid carcinoma of the middle ear: a case report.
Hu J, et al
Primary mucoepidermoid carcinoma of the middle ear is an exceptionally rare malignancy, and clinicians have very limited guidance on its diagnosis and treatment due to the scarcity of documented cases. This case report describes a 58-year-old woman who presented with seven months of purulent ear discharge followed by one month of bloody otorrhea, and was ultimately diagnosed with mucoepidermoid carcinoma of the middle ear after undergoing mastoidectomy. Initial treatment with radiation therapy at a total dose of 3,000 cGy proved insufficient, as the tumor recurred locally within nine months, requiring a major second surgical intervention involving subtotal temporal bone resection, partial parotidectomy, and neck dissection. Tragically, the patient died from tumor recurrence two years after the second surgery, illustrating the aggressive clinical course of this rare cancer and the limitations of current treatment approaches. This case highlights the importance of greater clinician awareness, early diagnosis, and development of more effective, evidence-based treatment protocols for rare malignancies of the middle ear.
Frontiers in surgery
Source →Testis-sparing surgery for Leydig cell tumor in children: long-term results of a multicentric retrospective cohort study.
Wei J, et al
A multicentric retrospective cohort study published in BMC Urology examined the long-term outcomes of testis-sparing surgery (TSS) in children diagnosed with Leydig cell tumors, which are rare benign testicular growths arising from hormone-producing cells. Researchers pooled data from multiple centers to assess oncological safety, recurrence rates, and the preservation of testicular function over extended follow-up periods. The findings support TSS as an effective and safe alternative to radical orchiectomy, avoiding unnecessary removal of the entire testicle in pediatric patients. Preserving testicular tissue is particularly important in children because it safeguards future hormonal production and fertility potential. These long-term results provide clinicians with stronger evidence to recommend organ-preserving approaches as the standard of care for pediatric Leydig cell tumors, reducing the physical and psychological impact of total orchiectomy on young patients.
BMC urology
Source →